← FDA Drug Approvals (Drugs@FDA)

BRIMONIDINE TARTRATE AND TIMOLOL MALEATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SABA ILAC SANAYIVE · Approved 2026-07-01

Drug application

FDA Application #

ANDA217934

Application type

Abbreviated New Drug Application (Generic)

Brand name

BRIMONIDINE TARTRATE AND TIMOLOL MALEATE

Generic name

Brimonidine Tartrate

Active ingredients

BRIMONIDINE TARTRATE; TIMOLOL MALEATE

Dosage form

SOLUTION/DROPS

Route

OPHTHALMIC

Marketing status

Prescription

Sponsor

SABA ILAC SANAYIVE

First approval

2026-07-01

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown